1.
J Antimicrob Chemother
; 52(2): 303-5, 2003 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12837732
RESUMO
Four hundred and eight clinical strains of Vibrio cholerae isolated from different geographical areas and with different antimicrobial resistance patterns were tested for susceptibility to rifaximin, a non-absorbable antibiotic active in vitro against Gram-negative bacteria. The MICs ranged from 0.5 to 4 mg/l for all strains. These values and the pharmacokinetic properties suggest rifaximin as an attractive antimicrobial agent for cholera.